Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;43(7):e35.
doi: 10.1136/jmg.2005.038125.

A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3

A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3

A S Brooks et al. J Med Genet. 2006 Jul.

Abstract

We report on a multigenerational family with isolated Hirschsprung's disease (HSCR). Five patients were affected by either short segment or long segment HSCR. The family consists of two main branches: one with four patients (three siblings and one maternal uncle) and one with one patient. Analysis of the RET gene, the major gene involved in HSCR susceptibility, revealed neither linkage nor mutations. A genome wide linkage analysis was performed, revealing suggestive linkage to a region on 4q31-q32 with a maximum parametric multipoint LOD score of 2.7. Furthermore, non-parametric linkage (NPL) analysis of the genome wide scan data revealed a NPL score of 2.54 (p = 0.003) for the same region on chromosome 4q (D4S413-D4S3351). The minimum linkage interval spans a region of 11.7 cM (12.2 Mb). No genes within this chromosomal interval have previously been implicated in HSCR. Considering the low penetrance of disease in this family, the 4q locus may be necessary but not sufficient to cause HSCR in the absence of modifying loci elsewhere in the genome. Our results suggest the existence of a new susceptibility locus for HSCR at 4q31.3-q32.3.

PubMed Disclaimer

Conflict of interest statement

Competing interests: there are no competing interests

Similar articles

Cited by

References

    1. Puri P. Hirschsprung's disease: Clinical Generalities. In: Holschneider A, ed. Hirschsprung's disease. 2nd ed. Amsterdam: Harwood Academic Publishers, 2000129–135.
    1. Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 200138729–739. - PMC - PubMed
    1. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaariainen H, Martucciello G. Point mutations affecting the tyrosine kinase domain of the RET proto‐oncogene in Hirschsprung's disease. Nature 1994367377–378. - PubMed
    1. Edery P, Lyonnet S, Mulligan L M, Pelet A, Dow E, Abel L, Holder S, Nihoul‐Fekete C, Ponder B A, Munnich A. Mutations of the RET proto‐oncogene in Hirschsprung's disease. Nature 1994367378–380. - PubMed
    1. Angrist M, Bolk S, Halushka M, Lapchak P A, Chakravarti A. Germline mutations in glial cell line‐derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet 199614341–344. - PubMed

Substances